Pharma Medico Aps
Financials

Generate report

Sections to include in the report.

Overview

Financial statement

Benchmark

Owners

Owners - diagrams

Management

History

Pharma Medico Aps

Graven 25B, 8000 Aarhus C, CVR 28665741

Industry: Manufacture of basic pharmaceutical products

Company type

Limited Corporation (APS)

Established

2006

Size

Micro

Employees

Revenue

- DKK

Gross profit

30 MDKK

Operating Profit (EBIT)

22 MDKK

Profit for the year

16 MDKK

Equity

52 MDKK

Overview
Rank
Financials
Management
Owners
History
Properties
Registration
Benchmark
Simulations

Settings

These settings also apply if you generate a report

Number of financial statements

Sorting order

Trend direction

Show details

Upload financial statement

The entered data can only be seen by you, and nobody else

Choose file to upload

Add comment

Enter financial statement

The entered data can only be seen by you, and nobody else

Date from

Date to

Currency code

Only show benchmark related fields

Number of employees

Income Statement

Revenue

Cost of Sales

Cost of production

Change in inventories of finished goods work in progress and goods for resale

Work performed by entity and capitalised

Other Operating Income

Property Cost

Administrative Expenses

Raw materials and consumables used

Other External Expenses

External Expenses

Gross Profit

Distribution costs

Wages And Salaries

Postemployment Benefit Expense

Social Security Contributions

Employee expenses transferred to assets

Other Employee Expense

Total Employee Benefits

Depreciation and Amortization

Writedowns of current assets other than current financial assets

Writedowns of current assets that exceed normal writedowns

Other Operating Expenses

Income from negative goodwill

Profit loss from ordinary operating activities before gains losses from fair value adjustments

Gains losses from current value adjustments of investment property

Gains losses from current value adjustments of other investment assets

Gains losses from current value adjustments of investment assets

Gains losses from current value adjustments of biological assets

Gains losses from current value adjustments of debt liabilities concerning investment property

Gains losses from current value adjustments of debt liabilities concerning other investment assets

Gains losses from current value adjustments of debt liabilities

Research expenditure

Development expenditure

Research and development expenditure

Operating Profit (EBIT)

Income from Investments in Group Enterprises

Income from Investments in Associates

Income from investments in participating interests

Income from investments in group enterprises and associates

Income from investments in joint ventures

Income from Other Long-term Investments and Receivables

Other Finance Income from Group Enterprises

Other finance income

Impairment of Financial Assets

Finance Expenses arising from Group Enterprises

Rest of other Finance Expenses

Other finance expenses

Profit Before Tax

Tax expense on ordinary activities

Profit loss from ordinary activities after tax

Extraordinary profit loss before tax

Tax expense on extraordinary events

Extraordinary profit loss after tax

Tax Expenses

Other Tax Expenses

Profit loss from discontinued operations

Profit loss from continuing operations

Profit for the year

Profit loss attributable to minority interest

Profit loss after attributable to minority interest

ÅRL supplement

Discounts given

IT expenses

Car expenses

Premises expenses

Losses recorded on debitors

Rental of operating equipment

Investments in fixed assets

Investments in intangible assets

Investments in financial assets

Assets

Concessions originating from development projects

Patents originating from development projects

Trademarks originating from development projects

Other similar rights originating from development projects

Completed development projects

Acquired concessions

Acquired patents

Acquired licences

Acquired trademarks

Acquired other similar rights

Acquired intangible assets

Goodwill

Development projects in progress

Prepayments for intangible assets

Development projects in progress and prepayments for intangible assets

Total Intangible Assets

Land

Buildings

Land and Buildings

Investment property

Other investment assets

Plant and Machinery

Fixtures Fittings Tools and Equipment

Biological assets

Leasehold Improvements

Ships

Planes

Rightofuse assets

Property plant and equipment in progress

Prepayments for property plant and equipment

Property plant and equipment in progress and prepayments for property plant and equipment

Total Property, Plant and Equipment

Long-term Investments in Group Enterprises

Long-term Investments in Associates

Longterm participating interests

Longterm investments in joint ventures

Longterm receivables from group enterprises

Longterm receivables from associates

Longterm receivables from participating interests

Other Long-term Investments

Other Long-term Receivables

Longterm receivables from owners and management

Noncurrent deferred tax assets

Deposits longterm investments and receivables

Cost exceeds income for the financial year longterm receivables

Contributed capital in arrears long term

Noncurrent contract assets

Total Long-term Investments and Receivables

Total Non-current Assets

Raw Materials and Consumables

Work in progress

Manufactured Goods and Goods for Resale

Prepayments for goods

Livestock

Assets held for sale inventories

Total Inventories

Short-term Trade Receivables

Contract Work in Progress

Short-term Receivables from Group Enterprises

Short-term Receivables from Associates

Shortterm receivables from joint ventures

Shortterm receivables from participating interests

Shortterm receivables dividends from group enterprises

Shortterm receivables dividends from associates

Shortterm receivables dividends from joint ventures

Shortterm receivables dividends from participating interests

Current Deferred Tax Assets

Short-term Tax Receivables

Shortterm tax receivables from group enterprises

Vat and duties receivables

Other Short-term Receivables

Contributed capital in arrears

Shortterm Receivables from Owners and Management

Deferred Income Assets

Cost exceeds income for the financial year shortterm receivables

Timing differences shortterm receivables especially utilities

Current contract assets

Derivative financial instruments shortterm assets

Total Short-term Receivables

Shortterm investments in group enterprises

Shortterm investments in associates

Investments in joint ventures

Other Short-term Investments

Total Short-term Investments

Total Cash and Cash Equivalents

Total Current Assets

Assets meant for sale

TOTAL ASSETS

Liabilities and Equity

Contributed Capital

Paid Contributed Capital

Share premium

Revaluation reserve

Reserve for net revaluation according to equity method

Reserve for loans and collaterals

Reserve for unpaid contributed capital

Reserve for entrepreneurial company

Reserve for development expenditure

Reserve for net revaluation of investment assets

Reserve for current value adjustments of currency gains

Reserve for current value of hedging

Other statutory reserves

Reserve according to articles of association

Reserve for biological assets

Rest of other reserves

Other reserves

Retained Earnings

Distributions

Proposed Dividend Recognised in Equity

Proposed extraordinary dividend recognised in equity

Not paid contributed capital

Hedge fund

Reserve fund

Transferred to from reserves available

Liquidation account

Actuarial profit loss which is a part of the calculation of contingent pensions

Equity attributable to parent

Minority interests

Total Equity

Provisions for pensions and similar liabilities

Provisions for Deferred Tax

Other provisions

Provisions for investments in group enterprises

Provisions for investments in group associates

Provisions for investments in participating interests

Provisions for investments in joint ventures

Provisions for income exceed cost for the financial year

Timing differences provisions especially utilities

Total Provisions

Shortterm debt to credit institutions

Short-term Mortgage Debt

Short-term Debt to Banks

Other shortterm debt raised by issuance of bonds

Short-term Debt to Other Credit Institutions

Convertible profit yielding or dividend yielding shortterm debt instruments

Shortterm Prepayments Received From Customers

Short-term Trade Payables

Shortterm bills of exchange payable

Short-term Payables to Group Enterprises

Shortterm payables to associates

Shortterm payables to participating interest

Shortterm payables to joint ventures

Short-term Tax Payables

Shortterm Tax Payables to Group Enterprises

Vat and duties payables

Other Short-term Payables

Holiday allowance liabilities shortterm

Shortterm deferred income

Shortterm negative goodwill

Shortterm lease commitments

Proposed dividend

Short-term Part of Long-term Liabilities other than Provisions

Shortterm equity loan

Short-term Payables to Shareholders and Management

Shortterm prepayments of work in progress

Shortterm contract work in progress liabilities

Shorterm derivative financial instruments liabilities

Deposits shortterm liabilities other than provisions

Income exceed cost for the financial year shortterm

Current contract liabilities

Total Current Liabilities

Longterm debt to credit institutions

Long-term Mortgage Debt

Long-term Debt to Banks

Other longterm debt raised by issuance of bonds

Longterm debt to other credit institutions

Convertible profit yielding or dividend yielding longterm debt instruments

Longterm prepayments received from customers

Longterm trade payables

Longterm bills of exchange payable

Longterm payables to group enterprises

Longterm payables to associates

Longterm payables to participating interests

Longterm payables to joint ventures

Longterm tax payables

Longterm tax payables to group enterprises

Other Long-term Payables

Holiday allowance liabilities longterm

Longterm deferred income

Longterm negative goodwill

Longterm lease commitments

Longterm equity loan

Longterm payables to shareholders and management

Longterm prepayments of work in progress

Longterm contract work in progress liabilities

Longterm derivative financial instruments liabilities

Deposits longterm liabilities other than provisions

Income exceed cost for the financial year longterm

Noncurrent contract liabilities

Total Non-current Liabilities excl. Provisions

Debt to credit institutions

Mortgage debt

Debt to banks

Other debt raised by issuance of bonds

Debt to other credit institutions

Convertible profit yielding or dividend yielding debt instruments

Prepayments received from customers

Trade payables

Bills of exchange payable

Payables to group enterprises

Payables to associates

Payables to participating interests

Payables to joint ventures

Tax payables

Tax payables to group enterprises

Other payables

Holiday allowance

Deferred income

Negative goodwill

Lease commitments

Equity loan

Payables to shareholders and management

Prepayments of work in progress

Contract work in progress liabilities

Derivative financial instruments liabilities

Deposits liabilities other than provisions

Income exceed cost for the financial year

Contract liabilities

Total Liabilities excl. Provisions

Liabilities related to assets meant for sale

TOTAL EQUITY AND LIABILITIES

Comment

Independence check

CVR

MNE

Period

Download documentation

Please note that the results are guiding only and we make reservations for any errors in the system or data.

Income Statement
	2022 365 days	2021 365 days	2020 366 days
	'000 DKK	'000 DKK	'000 DKK
Revenue	-	-	-
Gross Profit	30,301	19,238	10,687
Profit for the year	16,438	10,383	1,969
Assets
	2022 365 days	2021 365 days	2020 366 days
	'000 DKK	'000 DKK	'000 DKK
TOTAL ASSETS	63,767	48,216	36,267
Liabilities and Equity
	2022 365 days	2021 365 days	2020 366 days
	'000 DKK	'000 DKK	'000 DKK
Total Equity	51,511	39,573	29,190
TOTAL EQUITY AND LIABILITIES	63,767	48,216	36,267

No data

No Corona compensation data available

Pharma Medico Aps

Upload financial statement

Income Statement

Assets

Liabilities and Equity

Login at Bisbase

With a Bisbase account

Use another account